Haiqiang Mai

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 20, 2025
DDAH1 Promotes Cisplatin Chemoresistance in Patients with Locally Advanced Nasopharyngeal Carcinoma via the EGFR-JAK2-STAT3 Pathway.

Jin-Hao Yang, Li Yuan, Qiu-Yan Chen

|Jun 13, 2025
GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study.

Lin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang

|Mar 29, 2025
Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching.

Kaiqi Lan, Sailan Liu, Suchen Li

|Jan 08, 2024
Combined pre-treatment and middle-treatment Epstein-Barr virus DNA load contributes to prognostication and treatment modification in nasopharyngeal carcinoma patients.

Kaiqi Lan, Jingrong Mao, Xuesong Sun

|Sep 01, 2022
First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.

Zhen-Chong Yang, Ting Liu, Yan-Zhou Chen

|Aug 19, 2022
M1 stage subdivisions based on 18F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma.

Hui-Zhi Qiu, Xu Zhang, Sai-Lan Liu

Pageof 1

Frequent Collaborators

1 joint publications

Hui-Zhi Qiu

1 joint publications

Huan-Xin Lin

1 joint publications

Ling Guo

1 joint publications

Lin-Quan Tang